A proprietary research and development program targeting neuroscience, advanced therapeutics, and human-machine interaction. The company is establishing foundational R&D infrastructure focused on ultra-high-resolution neural sensing, real-time AI neural decoding, and next-generation interface design.

Expected impact: To build a new, long-term growth engine for the company in the global neurotechnology market. Currently, the program has not commenced human clinical trials, made regulatory submissions, or generated revenue.

Integration of DeepSeek's multimodal large-scale models, deep learning frameworks, and big data processing capabilities to upgrade the company's AI-powered diagnosis system and develop an AI-powered medical assistant.

Expected impact: To improve diagnostic efficiency and accuracy by integrating patient text, medical imaging, and lab results, while optimizing healthcare resource allocation and providing personalized treatment recommendations.

An initiative adopting an integrated model of 'Traditional Chinese Medicine (TCM) practice + modern medical technology' to coordinate and integrate third-party medical resources through licensed medical institutions, providing free in-hospital treatment plans for up to 10,000 eligible cancer patients.

Expected impact: To assess the scalability and feasibility of supporting sustainable and compliant healthcare accessibility within real-world medical systems, while maintaining a clear separation between corporate activities and regulated medical services.